Mental Help Net
Colds and Flu
Resources
Basic InformationLatest News
Clinical Trials Update: Nov. 20, 2009Trivalent Vaccine Has Minimal Effect on H1N1Clinical Trials Update: Nov. 17, 2009Immunity to Swine Flu May Be Broader Than ThoughtAnother Swine Flu Vaccine Approved for ChildrenCDC: New H1N1 Tracking Method Ups Estimates22 Million Sickened by Swine Flu in 6 MonthsRisk Communication Key to Keeping H1N1 Deaths DownOlder People at Greater Risk of Swine Flu DeathTamiflu-Resistant Swine Flu Found in Canadian FatherClinical Trials Update: Nov. 11, 2009Depressed and Pregnant? Flu Shot May Be NeededMost Who Want Swine Flu Shot Can't Get ItSwine Flu Virus Dominant Strain Worldwide: WHORest Easy. When It Comes to Swine Flu, Your Pet Is SafeStats Helps Paint Picture of H1N1 HospitalizationsCDC Urges Patience As More Swine Flu Shots ArriveIDSA: Attitudes Toward Flu Vaccination Vary at HospitalBackground Disease Rates Important in H1N1 PandemicOne Dose of Swine Flu Vaccine Works for Pregnant WomenFlu Deaths Higher Among Seniors With DementiaSwine Flu Radiographic and CT Imaging Patterns StudiedFlu Shot in Pregnancy Protects BabyAlmost 6 Million U.S. Cases of Swine Flu in First Few MonthsTamiflu-Resistant Swine Flu Passed Person-to-Person in U.S.Cholesterol Drugs May Help Prevent Flu Deaths1 Million More Doses of Swine Flu Vaccine on HandMore Swine Flu Vaccine Coming SoonH1N1 Can Be Particular Threat to Transplant RecipientsFar Fewer H1N1 Vaccine Doses Than Expected Are AvailableSebelius: There Will Be Swine Flu Vaccine for All Who Want ItProduction Problems Plague Delivery of Swine Flu VaccineCT Scans Surpass X-Rays for Swine Flu: StudySwine Flu Parties? Send Your Regrets, Experts SayNovel H1N1 Vaccine Found Effective for Most Age GroupsMost H1N1 Hospitalizations Are in Young PatientsSeasonal Flu Vaccine Approved for ChildrenMinnesota Pig Infected With H1N1 FluCDC Says New Child Deaths Raise H1N1 Beyond EpidemicTake the Sting Out of Your Child's Flu Shots11 More Children Die From Swine Flu: CDCSevere Swine Flu Could Lead to Blood Clots in Lungs: StudyMany Hospitalized With Swine Flu Had Been HealthyMany Americans Still Leery of Swine Flu VaccineH1N1 Has Made Many Young Adult Patients Critically IllSwine Flu Can Move Quickly to Severe Illness76 Children Dead From Swine Flu: CDCSwine Flu May Bring Surge in HospitalizationsIn Some Cities, Spring Swine Flu May Be Easing Fall OutbreakSebelius Urges Americans to Get Swine Flu Vaccine
VideosLinks
Community

Talk about this issue in our mental health support community

Related Topics

Medical Disorders
Medications

Background Disease Rates Important in H1N1 Pandemic

(HealthDay News)
by -- Rick Ansorge
Updated: Nov 2nd 2009

 

new article illustration

MONDAY, Nov. 2 (HealthDay News) -- During mass immunization with pandemic H1N1 influenza vaccines, awareness of background rates of disease is essential for assessing vaccine safety, and may help allay vaccine-associated fears among the general public, according to an article published online Oct. 31 in The Lancet.

Steven Black, M.D., of Cincinnati Children's Hospital, and colleagues identified background rates of selected medical events for several countries, and found a wide variation in the rates of disease events by age, sex, method of ascertainment, and geography.

Based on this data, the researchers estimated that the vaccination of 10 million people in the United Kingdom would be followed in six weeks by 21.5 coincident background cases of Guillain-Barre syndrome and 5.75 coincident background cases of sudden death. They also estimated that 397 out of every 1 million vaccinated pregnant women in the United States would have a miscarriage within a day of vaccination.

"Background rates can provide the media, the public, public-health officials, and politicians with important information about the expected number of events that can occur in the absence of any vaccination program," Black and colleagues conclude. "Additionally, they can be used to estimate the number of such events that will occur after immunization of any number of individuals."

Several authors reported financial relationships with GSK, Wyeth, Novartis, and Sanofi Pasteur.

Abstract
Full Text (subscription or payment may be required)
Comment (subscription or payment may be required)

Follow us on Twitter!

Find us on Facebook!





powered by centersite dot net